Peter Piferi's Insider Trades & SAST Disclosures
Peter Piferi's most recent trade in ClearPoint Neuro Inc was a trade of 4,406 Stock Options (right to buy) done . Disclosure was reported to the exchange on Aug. 20, 2021.
Add Superstar Alert
Note
This is a custom search result for pattern Peter Piferi.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
ClearPoint Neuro Inc
|
Peter Piferi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 4,406 | 4,406 | - | - | Stock Options (right to buy) | |
|
ClearPoint Neuro Inc
|
Peter Piferi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 2,203 | 68,739 (0%) | 0% | 0 | Common Stock | |
|
ClearPoint Neuro Inc
|
Peter Piferi | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.70 per share. | 15 Aug 2021 | 1,454 | 59,239 (0%) | 0% | 17.7 | 25,736 | Common Stock |
|
ClearPoint Neuro Inc
|
Peter Piferi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.60 per share. | 23 Jul 2021 | 20,000 | 64,549 (0%) | 0% | 2.6 | 52,000 | Common Stock |
|
ClearPoint Neuro Inc
|
Peter Piferi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2021 | 20,000 | 0 | - | - | Stock Options (right to buy) | |
|
ClearPoint Neuro Inc
|
Peter Piferi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2021 | 4,464 | 17,857 | - | - | Stock Options (right to buy) | |
|
ClearPoint Neuro Inc
|
Peter Piferi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.47 per share. | 23 Jul 2021 | 4,464 | 44,549 (0%) | 0% | 3.5 | 15,490 | Common Stock |
|
ClearPoint Neuro Inc
|
Peter Piferi | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.15 per share. | 23 Jul 2021 | 3,856 | 60,693 (0%) | 0% | 20.1 | 77,698 | Common Stock |
|
ClearPoint Neuro Inc
|
Peter Piferi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2021 | 3,141 | 12,565 | - | - | Stock Options (right to buy) | |
|
ClearPoint Neuro Inc
|
Peter Piferi | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.24 per share. | 23 Jul 2021 | 3,141 | 40,085 (0%) | 0% | 3.2 | 10,177 | Common Stock |
|
ClearPoint Neuro Inc
|
Peter Piferi | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.54 per share. | 09 Jul 2021 | 686 | 36,944 (0%) | 0% | 18.5 | 12,718 | Common Stock |
|
ClearPoint Neuro Inc
|
Peter Piferi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 15,706 | 15,706 | - | - | Stock Options (right to buy) | |
|
ClearPoint Neuro Inc
|
Peter Piferi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 9,259 | 37,630 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges